United States · Federal contract register · Supplier record

ISOLA THERAPEUTICS INC

Line: Health r&d services; health care services; experimental development (AN13)Register loaded to September 2026Compiled 6 October 2026

ISOLA THERAPEUTICS INC — United States · Federal contract register · Supplier record: 3 contracts, all years ($8,690,416 · Aug 2022 – Apr 2026); $7.5M since January 2024 (1 contract · 1 agency); 15th rank in the line (of 102 suppliers · 1.32%); 3 agencies never served ($80.8M on the line without ISOLA THERAPEUTICS INC).

Assay record ASY-US-1VHY7031DN · Cite as: Assay Systems, “ISOLA THERAPEUTICS INC in the USAspending register”, https://assay-systems.com/register/us/isola-therapeutics-inc/

3
contracts, all years
$8,690,416 · Aug 2022 – Apr 2026
$7.5M
since January 2024
1 contract · 1 agency
15th
rank in the line
of 102 suppliers · 1.32%
3
agencies never served
$80.8M on the line without ISOLA THERAPEUTICS INC

Own record by year

2022 onward
$455K
$750K
$7.5M
20222023202420252026

Who buys from ISOLA THERAPEUTICS INC

since January 2024
1agencies
$7.5Mpaid
100.0%top buyer
Department of Health and Human Services100.0%
$7,485,417

The line

since January 2024
$566Mline value
124contracts
4agencies
102suppliers
70.3%held by top ten

Health r&d services; health care services; experimental development (AN13)

$239M
$109M
$218M
202420252026Jan–Sep
15thof 102 suppliers
$7,485,417ISOLA THERAPEUTICS INC in the line
1.32%share of the line
1.5%of $485,502,671 spent by Department of Health and Human Services

Agencies that buy the line and never bought from ISOLA THERAPEUTICS INC

3agencies
61contracts
$80,752,756since January 2024
Department of Defense18 contracts
$50,693,667
Department of the Interior17 contracts
$26,151,140
Department of Veterans Affairs26 contracts
$3,907,948

How the line is bought

by value, since 2024
3%no competition
68%one applicant
0of these to ISOLA THERAPEUTICS INC
Competed, one supplier applied40 contracts
$386,070,664 · 68.2%
Competed, several suppliers applied54 contracts
$162,632,998 · 28.7%
Awarded directly, no competition30 contracts
$17,551,765 · 3.1%

Contracts reaching their end dates

Oct 2026 – October 2027
35contracts
$69,818,385end by October 2027
10end in September 2027 · $35.6M
21in agencies never served · $28.0M
$1.5M
$1.8M
$69.8K
$1.4M
$1.5M
$13.1M
$186K
$2.0M
$12.6M
$35.6M
Oct 262 contractsNov 263 contractsDec 261 contractJan 271 contractFeb 273 contractsMar 2710 contractsMay 271 contractJun 271 contractAug 273 contractsSep 2710 contracts

Suppliers next to it in the line

since January 2024
UNIVERSITY OF CALIFORNIA, LOS ANGELES1 contract · 1 agency
$9,188,827
ISOLA THERAPEUTICS INC
$7,485,417
AD ASTRA DIAGNOSTICS, INC.1 contract · 1 agency
$6,702,732
UNIVERSITY OF ROCHESTER1 contract · 1 agency
$6,671,830

All 102 suppliers in the line

The extract

Every buying office, every contract holder, value, number and end date behind the figures above.

Request extractSee a sample extract

Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.